Skip to content

Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in Zambia

Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in Zambia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05454852
Acronym
PREFER-Zambia
Enrollment
771
Registered
2022-07-12
Start date
2022-09-15
Completion date
2026-12-31
Last updated
2026-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV

Keywords

HIV, antiretroviral treatment, differentiated service delivery, retention in care, Zambia

Brief summary

With the advent of universal eligibility for HIV treatment (treat all) and same-day and community-based antiretroviral therapy (ART) initiation, retention in care after a patient has started ART remains the main challenge to achieving optimal outcomes in HIV treatment programs. Consistently across both time and geography, the highest risk for loss from care is during a patient's first six months after ART initiation, with about quarter of all patients not retained by the end of month 6. One of the reasons for the high attrition from care in this early retention period is that the model of care offered to most newly-initiating and re-initiating patients has barely evolved from its original outlines. Patients in their first six months on ART are generally not eligible for lower-intensity, patient-centered differentiated service delivery models that make remaining in care easier for experienced patients. Instead, most early patients must still make multiple clinic visits that include clinical consultations with providers, and most can receive only 1-2 month supplies of medications at a time. This protocol is for the PREFER-Zambia study, an activity of the Retain6 project. Retain6 aims to develop new models of care for patients' first six months on ART. PREFER-Zambia will collect data on patients' characteristics, clinical and non-clinical needs, and preferences for different types of services during their first six months after initiating ART. The investigators will conduct an observational, prospective cohort survey of newly-initiated or re-initiated adult ART patients at a selected set of 12 healthcare facilities in Zambia. Results are expected to inform the design of better models of service delivery for the early treatment period.

Interventions

OTHERSurvey

Interviewer-administered survey

OTHERFocus group

Focus group for selected participants

Sponsors

University of the Witwatersrand, South Africa
CollaboratorUNKNOWN
Clinton Health Access Initiative Inc.
CollaboratorOTHER
Bill and Melinda Gates Foundation
CollaboratorOTHER
Boston University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Living with HIV and on ART for 0-6 six months at the study site * ≥ 18 years old (18 and older considered adult for research purposes in Zambia) * Presented at the study site for routine HIV-related care * Provide written informed consent to participate.

Exclusion criteria

* Unable to communicate in any of the languages into which the questionnaire has been translated or that is known to the research assistant * Not physically, mentally, or emotionally able to participate in the study, in the opinion of the investigators or study staff * Unwilling to take the time required to complete the questionnaire on the day of consent

Design outcomes

Primary

MeasureTime frameDescription
Retention6 monthsNot missing a scheduled clinical or medication pickup visit during the first 6 months after treatment initiation by more than 28 days.

Countries

South Africa, Zambia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026